Search

everythinglearnresearchcommunity

for

Search:↓

People with early-onset androgenetic alopecia may have a higher risk of heart disease due to abnormal blood lipid levels.

Finasteride worsens heart damage from nandrolone decanoate but protects against cell damage.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

High uric acid levels link to male pattern baldness, especially in young men.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

Men with male pattern baldness are more likely to have heart disease risk factors, so they should get heart screenings early.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Finasteride effectively lowers specific hormone levels, helping monitor treatment progress.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Finasteride may treat baldness but less effective for those with 5α-reductase deficiency.

Human beard hair follicles change testosterone into other related hormones, but don't much change androstenedione into testosterone.

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.

Men with male-pattern baldness have higher levels of certain testosterone metabolites and may have more active androgen metabolism.

Testosterone and some of its forms can strongly stimulate oil gland growth in skin.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

Testosterone affects androgen receptors and lipid storage in cells, while DHEA does not convert to testosterone or affect these receptors in the same way.

Cabergoline is more effective and has fewer side effects than bromocriptine for treating women with hyperprolactinemic amenorrhea.

Higher doses of oestradiol implants improve bone density in postmenopausal women.

Long-term use of oral contraceptives, especially starting before age 20, may increase the risk of early-onset breast cancer.

Finasteride's sexual side effects not caused by androgen deficiency or SRD5A inhibition.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

Finasteride safely lowers DHT levels without affecting testosterone.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

PRP treatment helps hair growth in most cases, but more research needed.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

Finasteride affects urinary steroid profiles and can potentially hide steroid abuse in sports drug testing.